Selected research
Industry Research
Urine Drug Testing Service Industry Research Report 2026
Market perspective
The global Urine Drug Testing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Urine Drug Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Urine Drug Testing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Urine Drug Testing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Urine Drug Testing Service include Abbott, Labcorp, Quest Diagnostics, Millennium Health, Genesis Reference Labs, Concentra, DISA, Medigold Health and Keystone Laboratories, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Urine Drug Testing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Urine Drug Testing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Urine Drug Testing Service Market by Company
Abbott
Labcorp
Quest Diagnostics
Millennium Health
Genesis Reference Labs
Concentra
DISA
Medigold Health
Keystone Laboratories
Crystal Health
MedTox
Australian Clinical Labs
Dominion Diagnostics
Matrix Diagnostics
Dorevitch Pathology
Urine Drug Testing Service Segment by Type
On-site Testing
Laboratory-based Testing
Urine Drug Testing Service Segment by Application
Hospital
Clinic
Others
Urine Drug Testing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine Drug Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urine Drug Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine Drug Testing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Urine Drug Testing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-site Testing
- Laboratory-based Testing
Applications
- Hospital
- Clinic
- Others
Companies covered
- Abbott
- Labcorp
- Quest Diagnostics
- Millennium Health
- Genesis Reference Labs
- Concentra
- DISA
- Medigold Health
- Keystone Laboratories
- Crystal Health
- MedTox
- Australian Clinical Labs
- Dominion Diagnostics
- Matrix Diagnostics
- Dorevitch Pathology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Urine Drug Testing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-site Testing
- 2.2.3 Laboratory-based Testing
- 2.3 Urine Drug Testing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Urine Drug Testing Service Breakdown Data by Type
- 3.1 Global Urine Drug Testing Service Historic Market Size by Type (2021-2026)
- 3.2 Global Urine Drug Testing Service Forecasted Market Size by Type (2027-2032)
4 Urine Drug Testing Service Breakdown Data by Application
- 4.1 Global Urine Drug Testing Service Historic Market Size by Application (2021-2026)
- 4.2 Global Urine Drug Testing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Urine Drug Testing Service Market Perspective (2021-2032)
- 5.2 Global Urine Drug Testing Service Growth Trends by Region
- 5.2.1 Global Urine Drug Testing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Urine Drug Testing Service Historic Market Size by Region (2021-2026)
- 5.2.3 Urine Drug Testing Service Forecasted Market Size by Region (2027-2032)
- 5.3 Urine Drug Testing Service Market Dynamics
- 5.3.1 Urine Drug Testing Service Industry Trends
- 5.3.2 Urine Drug Testing Service Market Drivers
- 5.3.3 Urine Drug Testing Service Market Challenges
- 5.3.4 Urine Drug Testing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Urine Drug Testing Service Players by Revenue
- 6.1.1 Global Top Urine Drug Testing Service Players by Revenue (2021-2026)
- 6.1.2 Global Urine Drug Testing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Urine Drug Testing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Urine Drug Testing Service Head Office and Area Served
- 6.4 Global Urine Drug Testing Service Players, Product Type & Application
- 6.5 Global Urine Drug Testing Service Manufacturers Established Date
- 6.6 Global Urine Drug Testing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Urine Drug Testing Service Market Size (2021-2032)
- 7.2 North America Urine Drug Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Urine Drug Testing Service Market Size by Country (2021-2026)
- 7.4 North America Urine Drug Testing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Urine Drug Testing Service Market Size (2021-2032)
- 8.2 Europe Urine Drug Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Urine Drug Testing Service Market Size by Country (2021-2026)
- 8.4 Europe Urine Drug Testing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Urine Drug Testing Service Market Size (2021-2032)
- 9.2 Asia-Pacific Urine Drug Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Urine Drug Testing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Urine Drug Testing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Urine Drug Testing Service Market Size (2021-2032)
- 10.2 South America Urine Drug Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Urine Drug Testing Service Market Size by Country (2021-2026)
- 10.4 South America Urine Drug Testing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Urine Drug Testing Service Market Size (2021-2032)
- 11.2 Middle East & Africa Urine Drug Testing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Urine Drug Testing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Urine Drug Testing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.1.4 Abbott Urine Drug Testing Service Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Labcorp
- 12.2.1 Labcorp Company Information
- 12.2.2 Labcorp Business Overview
- 12.2.3 Labcorp Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.2.4 Labcorp Urine Drug Testing Service Product Portfolio
- 12.2.5 Labcorp Recent Developments
- 12.3 Quest Diagnostics
- 12.3.1 Quest Diagnostics Company Information
- 12.3.2 Quest Diagnostics Business Overview
- 12.3.3 Quest Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.3.4 Quest Diagnostics Urine Drug Testing Service Product Portfolio
- 12.3.5 Quest Diagnostics Recent Developments
- 12.4 Millennium Health
- 12.4.1 Millennium Health Company Information
- 12.4.2 Millennium Health Business Overview
- 12.4.3 Millennium Health Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.4.4 Millennium Health Urine Drug Testing Service Product Portfolio
- 12.4.5 Millennium Health Recent Developments
- 12.5 Genesis Reference Labs
- 12.5.1 Genesis Reference Labs Company Information
- 12.5.2 Genesis Reference Labs Business Overview
- 12.5.3 Genesis Reference Labs Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.5.4 Genesis Reference Labs Urine Drug Testing Service Product Portfolio
- 12.5.5 Genesis Reference Labs Recent Developments
- 12.6 Concentra
- 12.6.1 Concentra Company Information
- 12.6.2 Concentra Business Overview
- 12.6.3 Concentra Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.6.4 Concentra Urine Drug Testing Service Product Portfolio
- 12.6.5 Concentra Recent Developments
- 12.7 DISA
- 12.7.1 DISA Company Information
- 12.7.2 DISA Business Overview
- 12.7.3 DISA Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.7.4 DISA Urine Drug Testing Service Product Portfolio
- 12.7.5 DISA Recent Developments
- 12.8 Medigold Health
- 12.8.1 Medigold Health Company Information
- 12.8.2 Medigold Health Business Overview
- 12.8.3 Medigold Health Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.8.4 Medigold Health Urine Drug Testing Service Product Portfolio
- 12.8.5 Medigold Health Recent Developments
- 12.9 Keystone Laboratories
- 12.9.1 Keystone Laboratories Company Information
- 12.9.2 Keystone Laboratories Business Overview
- 12.9.3 Keystone Laboratories Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.9.4 Keystone Laboratories Urine Drug Testing Service Product Portfolio
- 12.9.5 Keystone Laboratories Recent Developments
- 12.10 Crystal Health
- 12.10.1 Crystal Health Company Information
- 12.10.2 Crystal Health Business Overview
- 12.10.3 Crystal Health Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.10.4 Crystal Health Urine Drug Testing Service Product Portfolio
- 12.10.5 Crystal Health Recent Developments
- 12.11 MedTox
- 12.11.1 MedTox Company Information
- 12.11.2 MedTox Business Overview
- 12.11.3 MedTox Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.11.4 MedTox Urine Drug Testing Service Product Portfolio
- 12.11.5 MedTox Recent Developments
- 12.12 Australian Clinical Labs
- 12.12.1 Australian Clinical Labs Company Information
- 12.12.2 Australian Clinical Labs Business Overview
- 12.12.3 Australian Clinical Labs Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.12.4 Australian Clinical Labs Urine Drug Testing Service Product Portfolio
- 12.12.5 Australian Clinical Labs Recent Developments
- 12.13 Dominion Diagnostics
- 12.13.1 Dominion Diagnostics Company Information
- 12.13.2 Dominion Diagnostics Business Overview
- 12.13.3 Dominion Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.13.4 Dominion Diagnostics Urine Drug Testing Service Product Portfolio
- 12.13.5 Dominion Diagnostics Recent Developments
- 12.14 Matrix Diagnostics
- 12.14.1 Matrix Diagnostics Company Information
- 12.14.2 Matrix Diagnostics Business Overview
- 12.14.3 Matrix Diagnostics Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.14.4 Matrix Diagnostics Urine Drug Testing Service Product Portfolio
- 12.14.5 Matrix Diagnostics Recent Developments
- 12.15 Dorevitch Pathology
- 12.15.1 Dorevitch Pathology Company Information
- 12.15.2 Dorevitch Pathology Business Overview
- 12.15.3 Dorevitch Pathology Revenue in Urine Drug Testing Service Business (2021-2026)
- 12.15.4 Dorevitch Pathology Urine Drug Testing Service Product Portfolio
- 12.15.5 Dorevitch Pathology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst